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THE ROLE OF RADIOBIOLOGY
Radiotherapy is one of the most effective treatments for cancer. 1) Eighty percent of cancer patients need radiotherapy at some time or other, either for curative or palliative purpose.
2) Although Radiation therapy is a common and important tool for cancer treatment the radio sensitivity of normal tissues adjacent to the tumor limits therapeutic gain. The responses of normal tissues to therapeutic radiation exposure range from those that cause mild discomfort to others that are lifethreatening. The speed at which a response develops varies widely from one tissue to another and often depends on the dose of radiation that the tissue receives. 1) For example, the combination of chemotherapy and irradiation produces hepatic toxicity when radiation is used in the treatment of intrahepatic tumors, Hodgkin's disease, or ovarian cancers and after bone marrow transplantation. 3) Radiation-induced liver disease (RILD) is a dose-limiting complication of liver irradiation and the treatment options for RILD are limited, and in severe cases, liver failure and death can occur. 4, 5) Considerable efforts are being devoted at the present time to the improvement of radiotherapy; one of the main ways in which such an improvement might be obtained is by exploiting radiobiological initiatives.
Radiobiology is the study of the action of ionizing radiation on living things.
6) The effects of radiation exposure that become apparent to the clinician or the patient during the weeks, months and years after radiotherapy are seen both in tumor tissues and in the normal tissues that surround a tumor and which are unavoidably exposed to radiation. The primary tasks of radiation biology as applied to radiotherapy are to explain observed phenomena, and to suggest improvements to existing therapies.
1)

IONIZING RADIATION
The absorption of energy from radiation in biologic material may lead to excitation or to ionization. If the radiation has sufficient energy to eject one or more orbital electrons from the atom or molecule, the process is called ionization, and that radiation is said to be ionizing radiation. The important characteristic of ionizing radiation is the localized release of large amounts of energy. For convenience it is usual to classify ionizing radiation as electromagnetic (x-or γ-rays) or particulate (electrons, protons, α-particles, neutrons, negative π mesons and heavy charged ions). 6) 
HOW DOES RADIATION INTERACT WITH CELLS?
In the past with the explanation of "Hit Theory" scientists believed that radiation causes free radicals to damage only the cell that is "hit" by direct ionization, but nowadays there is a new theory named "Bystander Effects". This theory proposes the idea that radiation causes free radicals to trigger cell-cell communication and cell-matrix communication to cells other than those which are "hit" by the direct ionization by means of direct cell contact or release of material. Initial radiation-induced changes to bystander cells are very frequent events, suggesting total tissue involvement. Bystander effects indicate that radiation-induced cancer is not a single cell event, but a tissue and organ response.
REACTIVE FREE RADICALS
It has long been recognized that the damaging effects of ionizing radiation are brought about by both direct and indirect mechanisms. The direct action produces disruption of sensitive molecules in the cells whereas the indirect actions of ionizing radiation occur when it interacts with water molecules in the cell, resulting in the production of highly reactive free radicals, such as
• OH,
• H, and . High energy radiation breaks chemical bonds and this creates free radicals, like those produced by other insults as well as by normal cellular processes in the body. The free radicals can change chemicals in the body. The half life of these free radicals is extremely short, (10 -6 -10 -10 seconds); however, they immediately react with any biomolecules in the vicinity and produce highly site-specific oxidative damage. These changes can disrupt cell function and may kill cells. An estimated 60%-70% of tissue damage induced by ionizing radiation is believed to be caused by
• OH radicals.
7)
One of the early effects of Ionizing Radiation is that it produces reactive oxygen species (ROS). ROS can induce the cellular antioxidant defense enzymes such as superoxide dismutase and glutathione peroxidase. 8) Reactive oxygen species (ROS) and free radicals induced by partial reduction of oxygen (O 2 ) react with cellular macromolecules (i.e., nucleic acids, lipids, proteins, and carbohydrates) and damage them. Major biomarkers of oxidative damage to living cells are (i) lipid peroxidation (LPO) products, comprising volatile hydrocarbons measurable in exhaled air, such as ethane and penthane, and isoprostanes and aldehydic products measurable in tissues and body fluids; (ii) DNAhydroxylation products (e.g., 8-hydroxy-2'-deoxyguanosine (8-OHdG)) and microscopic indices of damage such as chromosomal aberrations and micronuclei; and (iii) protein hydroxylation products such as oxidized amino acids.
9)
CRITICAL TARGET
Radiobiologists have long been recognized that the most critical target of ionizing radiation passing through living tissues is the DNA (genetic material) that is present in the nucleus and mitochondria of most cells. Exposure of cells to ionizing radiation results in immediate and widespread oxidative damages to DNA by both direct and indirect mechanisms.
10) About 60%-70% of cellular DNA damage produced by ionizing radiation is estimated to be caused by • OH, formed from the radiolysis of water. Of the DNA damage produced by • OH, oxidized bases, abasic sites, DNA-DNA intrastrand adducts, DNA single and double strand breaks, and DNA-protein cross-links are the most significant. These occur primarily by interaction of free radicals with DNA bases and, to a lesser extent, with DNA sugars. 9) DNA damage caused by radiation exhibits multiply damaged sites and clustered legions. Among bases and, generally among nucleic acid components, guanine is the most susceptible DNA target for oxidative reactions mediated by • OH and other free radicals, and it exhibits the lowest ionization potential. Thus, one of the most mutagenic lesions, and the most abundant lesion formed in irradiated chromatin is 8-hydroxyguanine. [11] [12] [13] [14] Once formed, this product can be repaired by several mechanisms. 15) Under laboratory conditions, one of the most common and abundant measurable oxidative DNA base adducts is 8-OHdG. This is reported to be a key biomarker related to carcinogenesis. 16) The increased oxidation of guanine bases after exposure to ionizing radiation has been observed in numerous studies as well as in different tissues and species. 11, [16] [17] [18] The interaction of free radicals with sugar moieties leads to the cleavage of the sugar-phosphate backbone of DNA followed by single-strand breaks that undergo repair processes relatively easily. 9) On the other hand, double-strand breaks have more serious consequences. Double-strand breaks are well correlated with the cytotoxic effects of ionizing radiation and are considered the primary lesion involved in cellular death. 19) If DNA repair mechanisms, which are induced after exposure to ionizing radiation, are inefficient, the damaged DNA strands that are copied during replication lead to mutagenesis and carcinogenesis.
9) The damaging effects of ionizing radiation lead to cell death and are associated with an increased risk for numerous genetically determined diseases. 16 ) Among other indices of DNA damage caused by ionizing radiation are chromosome aberrations and micronuclei formation; these are apparent when irradiated cells are observed microscopically. [19] [20] [21] [22] [23] [24] [25] [26] Besides DNA, lipids and proteins are also attacked by free radicals induced by ionizing radiation. 27, 28) 
EFFECTS OF DNA DAMAGE
The effects can be enumerated as Gene Expression, Gene Mutation, Chromosome Aberrations, Genomic Instability and Cell Killing. Now the question is how these damages from ionizing radiation affect our bodies. Very high doses of radiation can cause serious and immediate effects (acute effects). After whole body exposure to very large doses of radiation, particularly sensitive cells die, resulting in serious damage to select organs and systems. While, a sufficient genetic alteration may lead to cancer a sufficient cell killing contributes to Radiation Sickness (Table.1 ). Radiation sickness is caused by damage to organs or systems after exposure to very high doses of radiation. The symptoms depend upon the dose and time of exposure.
High doses of radiation can also produce effects long after the exposure (late effects) resulting in adverse health effects within a short time of minutes (CNS Syndrome), days (GI Syndrome) to weeks (Hematopoetic Syndrome) or delayed effects observable many months (Birth defects, LD50) or years (Cancer) after exposure.
Radiation-induced mutations in a germ cell can lead to heritable changes that may not be expressed for many generations. The manifestation of unfavorable health effects depends on the radiation dose, duration of exposure, sensitivity of the tissues and intrinsic antioxidant defense mechanism(s). 7) Since the amount of DNA damage caused by ionizing radiation is correlated with the intensity of oxidative stress, with the efficacy of defense mechanisms that metabolize toxic intermediates and with intrinsic repair mechanisms, 9) there are several potential means to reduce macromolecular damage due to ionizing radiation. Because radiation-induced cellular damage is primarily due to the harmful effects of free radicals, molecules with direct free radical scavenging properties are particularly named as radioprotectors.
7)
RADIOPROTECTIVE AGENTS
The involvement of free radical scavengers in protecting against radiation damage is highlighted when scientists found out that whole body irradiation decreases the total antioxidant capacity of the organism and the levels of known antioxidants such as ascorbic acid and uric acid is depleted.
9)
The ability of certain substances to provide protection against the damaging effects of ionizing radiation was first published in 1949.
31) The best known radioprotectors are the sulfhydryl compounds, such as cysteine 32) and cysteamine. 33) However, these compounds produce serious side effects, such as nausea and vomiting, and are considered to be toxic at the doses required for radioprotection. With the memory of devastating effects of nuclear bombs detonated in Nagasaki and Hiroshima vivid in the years following World War II, a development program was initiated in the late 1950s by the United States Army. The Walter Reed Army Research Institute synthesized and tested over 4,000 compounds in an attempt to find a useful radioprotector, one that would protect against ionizing radiation without toxic side effects. The most effective compound of this type, originally tested against lethal doses of X-rays and gamma rays in mice, is WR-2721, the common name of which is amifostine. 34) Although amifostine was reported to be tolerated well in radiotherapeutic clinical trials, it was later found to have some undesirable side effects. These include hypotension, nausea, vomiting, sneezing, hot flashes, mild somnolence, and hypocalcemia. These side effects are severe enough to limit the amount of the drug required to levels lower than necessary to achieve maximal radioprotection. [35] [36] [37] [38] Moreover, WR-2721 must be given i.v. or s.c., which limits its utility outside of controlled clinical situations. 7) Walden et al. studied the radioprotective potential of 16,16-dimethyl prostaglandin E2 (DiPGE2), a synthetic derivative of prostaglandin E 2, and reported that subcutaneous administration of mice with DiPGE2 prior to wholebody exposure to 60Co-gamma irradiation (LD 50r30 dose) enhanced their survival. The degree of protection was found 
Ovaries/ Testes
Sterility 60,000-80,000 mrem/ 250,000-600,000 mrem to be dependent on both the time of administration and the dose of DiPGE2. The authors suggested that the radioprotection resulted from the physiologic action of DiPGE2 rather than direct in vivo detoxification of radicals.
39)
MELATONIN: A REMARKABLE RADIOPROTECTOR
Because of limited successes achieved over the years, testing radioprotective efficacy of a number of compounds, there is still an urgent need to identify novel, nontoxic, effective, and convenient compounds to protect humans from the damaging effects of ionizing radiation. In the last decade, the hydroxyl radical scavenging ability of melatonin was used as a rationale for testing its radioprotective ability. 7) Melatonin (N-acetyl-5-methoxytryptamine), which was discovered about 40 years ago, an endogenous compound synthesized by the pineal gland in the human brain ( Fig. 1) , has been reported to participate in the regulation of a number of physiological and pathological processes.
39) It was initially recognized as a molecule related to neuroendocrine physiology, especially reproductive physiology. Thereafter, melatonin was found to be involved in the control of circadian rhythms and possibly sleep processes in diurnal species. 9) Its concentrations in the body are typically lower during the day and reach maximal levels at night in the darkness. 7) Once synthesized in the pineal gland, melatonin is quickly released into the bloodstream and thence into other body fluids, such as bile, cerebrospinal fluid, saliva, ovarian follicular fluid, semen, and amniotic fluid; small amounts of unmetabolized melatonin are excreted in the urine, as well. There is clear evidence that melatonin levels decrease with increasing age in mammals, including man. However, the ability to synthesize melatonin, in terms of phasing and amplitude, is rather constant in a given person, although there is marked variability among individuals. There is some evidence suggesting that a seasonal variation exists in the synthesis of melatonin in humans, the levels possibly being higher in winter than in summer.
7) The half-life of melatonin in the serum has been calculated to be between 30 and 57 min. 40) In order to determine melatonin potential toxicity a wide range of doses, from physiologic to pharmacologic concentrations, has been tested in different animal species. Doses of melatonin that have been tested in in vivo investigations were as follows: 10-250 mg/kg in mice, 41, 42) 100-200 mg/kg in rats, 43, 44) or even 800 mg/kg in mice, rabbits, cats, and dogs. The results of these and many other studies indicate that both the acute and chronic toxicity of melatonin is extremely low. In human volunteers, oral administration of melatonin in doses of 1-300 mg or 1 gram of melatonin daily for 30 days resulted in no observable negative side effects. Sebra et al. conducted a randomized double-blind clinical trial in healthy adult male subjects by oral administration of melatonin (10 mg/day for 28 days, or a placebo) and reported no evidence of toxicity. 7) It has been demonstrated that melatonin was produced in some tissues including retina and lens. While pineal melatonin passes freely through membranes and distributes in all body compartments, retinal melatonin is thought to act locally within the eyes. 45) Melatonin is a potent antioxidant, which can exert its action directly or indirectly. In vitro experiments indicated that melatonin was 5-and 14-fold more potent than glutathione and mannitol, respectively, in scavenging hydroxyl radicals. 46) In addition to its direct free radical scavenging action, melatonin has been reported to increase the activity of some important antioxidant enzymes at molecular level, including superoxide dismutase and glutathione peroxidase. 47) Also, melatonin decreases the activity of nitric oxide synthase, a pro-oxidative enzyme.
46)
RADIOPROTECTIVE EFFICACY OF MELATONIN AGAINST IONIZING RADIATION
Melatonin is an important antioxidant as an efficient neutralizer of hydroxyl radical (
• OH). When melatonin interacts with the • OH, it becomes the indolyl (melatonyl) radical. This reactant has very low toxicity so there is a net gain when melatonin scavenges the • OH, and thus a highly toxic reactant is replaced by a radical with low toxicity. After some molecular rearrangement the indolyl radical scavenges a second
• OH to form cyclic 3-hydroxymelatonin. This product has been identified by electron ionization mass spectrometry and protein nuclear magnetic resonance. 48) Radiation-induced lipid peroxidation is a free radical process.
3) The process of lipid peroxidation is one of oxidative conversion of polyunsaturated fatty acids to several products including as malondialdehyde (MDA) and lipid peroxides. Malondialdehyde, because of its high cytotoxicity and inhibitory actions on protective enzymes, acts as a tumor promoter and a co-carcinogenic agent. 29) Malondialdehyde is the end product of lipid peroxidation and serves as an index of oxidative damage. 30) Melatonin also restricts lipid peroxidation by preventing the initiating events as well as interrupting the chain reaction. 49) Melatonin can also directly scavenge hydroxy radical, peroxyl radical, peroxynitrite anion and singlet oxygen protecting cell membrane, proteins in the cytosol and DNA in the nucleus. This tryptophan derivative further stimulates a number of antioxidative enzymes and stabilizes cell membranes. Not only is melatonin an effective antioxidant but the products it generates also appear to reduce oxidative damage. For example, the product, N 1 -acetyl-N 2 -formyl-5-methoxykynuramine (AFMK), may also be an effective scavenger. 49) This cascade of reactions contributes to the overall antioxidative potential of melatonin. Dioxetane is also one proposed intermediate product although there may be others as well. 48) Melatonin also stimulates brain glutathione peroxidase (GSH-Px) activity, 49) and may be the only known antioxidant to have such dual effects. Actually, the first study that revealed the antioxidative effects of melatonin to a physical agent was conducted using ultraviolet light (UV), which shares many features with ionizing radiation. In 1993, Tan et al. reported that melatonin scavenges
• OH generated in vitro when H2O2 was exposed to ultraviolet light. In vivo as well, UV light damage to the skin is known to be prevented by melatonin. Using a similar model, the potency of melatonin in protecting against
• OH generated by ionizing radiation was confirmed under in vivo conditions. 9) In the meantime, a number of studies have tested melatonin's efficacy in protecting against ionizing radiation both in vivo and in vitro. 9) Vijayalaxmi et al. 22, 23) conducted the initial in vitro studies using melatonin as a cytoprotective agent for human cells exposed to ionizing radiation. The investigators treated human blood lymphocytes with increasing concentrations of melatonin for 20 min, and the cells were then exposed to 150 cGy gamma radiation. The data indicated a significant reduction (~60%) in the incidence of abnormal cells showing genetic damage, exchange type of aberrations, acentric fragments, and micronuclei as compared with similarly irradiated cells that were not pretreated with melatonin. The satisfactory cytoprotection against radiation observed in in vitro treatments with melatonin led to subsequent in vivo/in vitro investigations where a single oral dose of 300 mg of melatonin was given to healthy human volunteers. 24) Vijayalaxmi et al. 26) proposed that melatonin, in addition to its ability to scavenge radiation-induced hydroxyl radicals, the indole may activate enzyme(s) involved in the repair of lesions in cellular DNA. Further studies are required to prove this hypothesis. 7) Investigations regarding the influence of ionizing radiation on humans have obvious limitations. The initial in vitro studies that used human tissues to test the protective effects of melatonin against ionizing radiation-induced damage were done by Vijayalaxmi et al.. 22) The authors used human peripheral blood lymphocytes that are not only easy to obtain but also highly radiosensitive, and both ionizing radiation and melatonin were applied to cultured cells. Cells exposed to γ-irradiation at a dose of 1.5 Gy exhibited a pronounced increase in chromosome damage; this was verified by the increased incidence in abnormal cells, an augmentation of exchange-type aberrations, and a rise in the frequency of acentric fragments. Preincubation (20 min) with melatonin at concentrations of either 0.5, 1.0, or 2.0 mM reduced concentration dependently the incidence of abnormal cells by 31.3%, 47.8%, and 61.9%, the incidence of exchange chromosomes by 34.3%, 53.3%, and 68.0%, and the frequency of acentric fragments by 42.4%, 53.5%, and 67.8%, respectively. Already in 1994, Blickenstaff et al. 50) carried out studies illustrating the radioprotective actions of melatonin in Swiss ND4 mice. They noted that their exposure to 950 cGy of whole body radiation caused the death of all animals 12 days later, whereas when mice were pretreated with melatonin (1.076 mmol/kg body wt), 43% of the irradiated mice survived at least 30 days after treatment. Interestingly, homologs of melatonin obtained by acylation of 5-methoxytryptamine revealed protective effects against ionizing radiation as well; maximal survival rate was achieved with homologs having acyl chain lengths of six or eight carbons. 9) A similar survival study was conducted by Vijayalaxmi et al. using CD2-F1 mice. They observed that the exposure of mice to 815 cGy of ionizing radiation resulted in only a 45%-50% survival rate after 30 days; pretreatment with melatonin at a dose of 125 mg/kg body wt slightly increased the survival rate to 60%, whereas melatonin at a dose of 250 mg/kg body wt significantly increased survival to 85%.Other studies have examined lipid damage after ionizing radiation and the protective effects of melatonin. Exposure of Wistar female rats to ionizing radiation at two doses of 360 cGy radiation given in an interval of 12 hr, brought about, expectedly, significant increases in the levels of MDA in ovaries and plasma 6 hr after radiation exposure. 44) Pretreatment of the rats with melatonin at a dose of 100 mg/kg body wt decreased the level of MDA in both tissues when compared with that in irradiated animals. A study performed on Wistar:Han SPF rats has found that melatonin administered in drinking water (dose not specified) for 15 days prevented the increase in hepatic lipids and thymic triacylglycerol levels caused by continuous irradiation at a daily dose of 96 mGy and/or dimethylbenz(a)anthracene treatment, also given daily for 15 days. 9) Experiments have also been performed to examine the early effect of ionizing radiation on both in vivo DNA and membrane damage in rats. Whole body irradiation at a dose of 800 cGy to Sprague-Dawley male rats increased oxidation of guanine bases in DNA isolated from liver collected 12 hr later (Karbownik et al., unpublished data) . Similarly, radiation exposure decreased membrane fluidity of hepatic microsomes, although it did not influence lipid breakdown as evaluated by the level of MDA+4-HDA in liver and other tissues. These early effects of ionizing radiation on DNA damage and membrane fluidity were, expectedly, prevented by melatonin injected at a dose of 50 mg/kg body wt at 120, 90, 60, and 30 min prior to radiation exposure. Whole body irradiation at a dose of 1.5 Gy brought about a marked increase in the frequency of micronuclei in polychromatic erythrocytes and of chromosomal aberrations in spermatogonia and spermatocytes 24 hr later. 51) Melatonin given at a dose of 10 mg/kg body wt, 1 hr prior to irradiation, significantly decreased the effects of this exposure. The authors of the present survey underline that they do not entirely agree with the interpretation of the results in the report by Badr et al.. Their conclusion related to "a cytotoxic effect of melatonin at a relatively high dose (10 mg/kg body wt)" is not supported, in the opinion of the authors of the present survey, by either their findings 51) or other literature. The very small increase in micronuclei in polychromatic erythrocytes after a 10 mg/kg body wt dose of melatonin, when compared with the effect of ionizing radiation, would seem irrelevant. Worth underlining is the fact that melatonin did not influence any other examined parameter of chromosomal damage and, when applied before exposure to radiation, not after, decreased the damaging effect of ionizing radiation in all measured parameters, micronuclei included, Badr et al. 51) strongly suggested that the presence of melatonin during radiation exposure is essential to its radioprotective effect. The finding that melatonin after irradiation provides no radioprotective effect indicates that melatonin should be inside the cell at the time of exposure to radiation in order to confer protection. Melatonin administration prior to irradiation may prevent rat liver damage induced by irradiation, reflecting the antioxidant roles of different doses of melatonin against gamma-irradiation-induced oxidative damage after total body irradiation with a single dose of 6Gy.
52) The liver tissue MDA levels in irradiated rats that were pre-treated with melatonin (5 or 10 mg/kg) were significantly decreased, while the SOD and GSH-Px activities were significantly increased. The prophylactic influence of melatonin against radiomimetic drug cyclophosphamide-induced oxidative stress in mouse tissues showed modulatory effect on lipid peroxidation, GSH, glutathione disulphide (GSSG), GSH-Px and serum phosphatase levels in brain, spleen liver, lungs, kidney and testes. 53) Monobe et al. found out that oral administration of melatonin was effective for rats. The protective effects of melatonin on g-ray induced intestinal damage depend on the plasma melatonin concentrations, and the peak of the protection was 0.5 h after melatonin administration.
54)
MELATONIN: AN ANTICANCER AGENT
Melatonin, as a new member of an expanding group of regulatory factors that control cell proliferation and loss, is the only known chronobiotic, hormonal regulator of neoplastic cell growth. At physiological circulating concentrations, this indoleamine is cytostatic and inhibits cancer cell proliferation in vitro via specific cell cycle effects. At pharmacological concentrations, melatonin exhibits cytotoxic activity in cancer cells. At both physiological and pharmacological concentrations, melatonin acts as a differentiating agent in some cancer cells and lowers their invasive and metastatic status through alterations in adhesion molecules and maintenance of gap junctional intercellular communication. In other cancer cell types, melatonin, either alone or in combination with other agents, induces apoptotic cell death. 55) There are data which indicate that melatonin antagonizes the mitogenic effects of estrogens. 49) Inhibition of antioxidants by reducing agents such as glutathione eliminates the oncostatic effects of melatonin in certain human breast cancer cell lines. 56) As stated above, melatonin has been found to be the most effective scavenger of highly toxic free radicals, which induce DNA damage. Melatonin may augment the anti tumor activity of IL-2 (interleukin 2) by inhibiting tumor growth factor production. These results suggest that low-dose IL-2 and melatonin may be a well tolerated therapy for advanced endocrine tumors. Melatonin may also enhance IL-2 anti tumor immune effect. 49) Melatonin reduces tumor growth in experimental models in vivo 57) and proliferation and invasive properties of cancer cells in culture. 58) Oral supplementation of melatonin reduced the viability and volume of the tumor Ehrlich ascites carcinoma cells (EAC) implanted intraperitoneally into female mice, delayed the progression of the cell cycle and reduced the DNA content of the cells. The depressed cell viability suggests that melatonin might be inducing apoptosis in EAC cells. The proapoptotic action of melatonin in cancer cells is not restricted to breast tissue. Melatonin also suppresses the proliferation of a colon cell line both in vitro and in vivo. In addition, the proliferating/apoptotic cell ratio in this cell line, originally developed from a 1,2-dimethylhydrazine-induced colonic tumor in mouse, was significantly lower when the animals were treated with melatonin, indicating that it also induces apoptosis. 49) Mills et al. in a systematic review of randomized controlled trials and metaanalysis reported the substantial reduction in risk of death, low adverse events and low cost of melatonin suggest great potential for melatonin in treating cancer in humans.
59)
MECHANISM OF ACTION AND DNA REPAIR
The radioprotectors can elicit their action by various mechanisms, such as: 1) suppression of the formation of reactive species, 2) detoxification of radiation induced species, 3) target stabilization and 4) enhancing the repair and recovery processes.
2)
The ability for cells to repair themselves after radiationinduced DNA damage may support a threshold, or amount of radiation below which no permanent damage is done. Unique radiation-induced DNA damage may not be repaired easily, and could support the Linear no threshold hypothesis which says any amount of radiation can cause permanent damage. Radiation-induced DNA damage must be specifically linked to a disease before it can be assumed that radiation damage increases health risks from that disease. For example, damage that can be completely repaired does not necessarily equate with cancer.
Understanding the mechanisms of DNA damage and repair will help more accurately determine risk from different levels of radiation.
Repair saturation models in radiobiology demonstrate the idea that if the repair enzymes become saturated (Fig. 2) , there is not enough repair enzymes left for binding to all damaged sites simultaneously and so the reaction velocity of repair no longer increases with increasing damage. There is an alternative "saturation" hypothesis, leading to the same consequence, which the pool of repair enzymes is used up during repair, so that at higher doses the repair system is depleted and is less able to repair all the induced damage. 1) Exogenously administered and endogenously synthesized melatonin has been shown to concentrate more in the nucleus than in the cytosol of the cell. The small size, high lipophilicity, membrane and nuclear receptor-mediated, as well as the receptor-independent actions of melatonin account for its multitude of actions on cells. Based on these reports and the observed protective influence of melatonin against radiation-induced genetic damage, the following experimental hypotheses are proposed by Vijayalaxmi et al. (Fig. 3) , melatonin in the nucleus will bestow a direct protection by reducing the extent of primary DNA damage by scavenging the radiation induced free radicals, including the hydroxyl radical. The melatonin acting at the membrane and in the cytosol will generate 'signal(s)' that trigger the activation of one or more of the existing DNA repair enzymes, and/or activation of a set of gene(s) that lead to de novo protein synthesis associated with DNA repair (this could be mediated through protein kinase C)". 26) Here melatonin can be hypothesized to play a crucial role: according to this hypothesis by Vijayalaxmi et al, melatonin may postpone the saturation of repair enzymes which leads to repairing more induced damage by repair system and more importantly allows the use of higher doses of radiation during radiotherapy.
There is now compelling evidence that melatonin may reduce the incidence 60) and certainly the growth of tumors. 61) For melatonin to achieve these effects, it seems several mechanisms are involved. In terms of limiting the frequency of cancer initiation, one of the mechanisms may be the ability of melatonin to reduce severe DNA damage. 62) DNA can, of course, be repaired, a process that may be hastened by melatonin. Once tumors are formed, melatonin also seems to control their growth. Certainly, the classic work of Blask et al. 63) has defined a mechanism which accounts for melatonin's ability to limit the growth of cancer cells.
OPTIMAL DOSE
Although compelling evidence suggests that melatonin may be effective for a variety of disorders, the mode and optimal dose of melatonin is still not clear. 49) Most studies have used doses of supra-physiological blood levels. However, doses as low as 0.1 mg/kg given orally to mice proved the effective and appropriate minimum dose level of melatonin 58, 64) at which age-induced changes in the levels of MDA, GSH, GSSG, GSH-Px and phosphatase activity have been shown to improve. This level of melatonin ameliorates the depletion of GSH as well as the fall of GSH-Px and alkaline phosphatase activities and reduces the level of GSSG, lipid peroxidation and acid phosphatase in mice. Pre-treatment with the same dose level (0.1 mg/kg/day) for 15 consecutive days affords potential protective effect against radiation induced oxidative stress and mortality in mice. It has been reported 41) that melatonin (at a dose as high as 250 mg/kg) is non-toxic and that high doses of melatonin are effective in protecting mice from lethal effects of acute whole-body irradiation. The effects on low-level chronic administration of melatonin against radiation induced injury have also been shown to be quite effective. [63] [64] [65] 
CONCLUDING COMMENTS
This article reviews different features that make melatonin a potentially useful radioprotector such as direct and indirect scavenging of free radicals; the ability to stimulate the activity of antioxidant enzymes and to inhibit the activity of a pro-oxidative enzyme; distribution in all tissues, cells, and cellular compartments throughout the organism; quick diffusion through all biological membranes; ability to provide radioprotection without receptor interaction; tolerance to high doses of melatonin by living organisms and little toxicity in the species tested; ease of oral administration and etc.
According to repair saturation models in radiobiology and melatonin's possible mechanism involving in its radioprotective effects (Vijayalaxmi et al.) , we hypothesized that melatonin may postpone the saturation of repair enzymes which leads to repairing more induced damage by repair system and more importantly allows the use of higher doses of radiation during radiotherapy.
Besides radioprotective effects of melatonin against cellular damage caused by oxidative stress, its considerable potential as a new anticancer hormone/drug provides a biological explanation of melatonin-induced enhancement of the efficacy and reduced toxicity of chemo-and radiotherapy in cancer patients. Therefore, we propose that, in the future, melatonin improve the therapeutic ratio in radiation oncology.
There is continued interest and need for the identification and development of non-toxic and effective radioprotective compounds. Such compounds could potentially protect humans against the genetic damage, mutation, immune system alterations, and teratogenic effects of toxic agents which act through the generation of free radicals. In hundreds of investigations, melatonin appears to be the effective and non-toxic radioprotector desired. Also there are numerous findings which uniformly suggest that melatonin is influential in inhibiting both cancer initiation and cancer cell growth.
The implications of the accumulated observations suggest by virtue of melatonin's radioprotective and anticancer effects it is time to use it as a radioprotector both for radiation workers who are unavoidably exposed to radiation and patients suffering from cancer either alone for cancer inhibition or in combination with traditional radiotherapy for getting a favorable efficacy/toxicity ratio during the treatment. The optimum dose of melatonin for human radioprotection, however, is yet to be determined. 41) 
